GO
Loading...

Johnson & Johnson

More

  • Midday Glance: Medical Devices companies Thursday, 24 Jul 2014 | 1:23 PM ET

    Allergan fell$. 78 or. 5 percent, to $171.65. Baxter International Inc. rose$. 20 or. 3 percent, to $77.04. Boston Scientific Corp. rose$. 09 or. 7 percent, to $13.11.

  • Early Glance: Pharmaceuticals companies Thursday, 24 Jul 2014 | 11:37 AM ET

    Baxter International Inc. fell$. 13 or. 2 percent, to $76.71. Bristol-Myers Squibb Co. fell$. 16 or. 3 percent, to $49.16. Hospira rose$. 03 or. 1 percent, to $50.69.

  • Early Glance: Medical Devices companies Thursday, 24 Jul 2014 | 11:37 AM ET

    Allergan fell $1.51 or. 9 percent, to $170.92. Baxter International Inc. fell$. 13 or. 2 percent, to $76.71. Boston Scientific Corp. rose$. 02 or. 2 percent, to $13.04.

  • Final Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 6:02 PM ET

    Allergan fell$. 71 or. 4 percent, to $170.43. Boston Scientific Corp. rose$. 30 or 2.4 percent, to $12.85. Medtronic rose$. 30 or. 5 percent, to $62.71.

  • Final Glance: Pharmaceuticals companies Tuesday, 22 Jul 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 76 or 1.0 percent, to $76.87. Bristol-Myers Squibb Co. rose$. 20 or. 4 percent, to $49.12. Hospira rose$. 31 or. 6 percent, to $50.78.

  • Midday Glance: Pharmaceuticals companies Tuesday, 22 Jul 2014 | 1:57 PM ET

    Baxter International Inc. rose$. 93 or 1.2 percent, to $77.04. Bristol-Myers Squibb Co. rose$. 41 or. 8 percent, to $49.33. Hospira rose$. 27 or. 5 percent, to $50.74.

  • Early Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 11:16 AM ET

    Allergan rose $1.04 or. 6 percent, to $172.18. Baxter International Inc. rose$. 55 or. 7 percent, to $76.66. Boston Scientific Corp. rose$. 23 or 1.8 percent, to $12.78.

  • J&J buying back $5 billion worth of its shares Monday, 21 Jul 2014 | 6:17 PM ET

    NEW BRUNSWICK, N.J.— Johnson& Johnson, the world's biggest maker of health care products, plans to buy back up to $5 billion of the company's common stock. Johnson& Johnson's shares have risen strongly over the past two years, from about $68 to a July 7 all-time closing high of $106.47.

  • July 18- Advertising company Interpublic Group of Cos Inc reported better-than-expected quarterly revenue, boosted by strong growth in the UK and higher ad spending in its core U.S. market. Interpublic's clients include General Motors, Unilever and Johnson& Johnson.

  • Early Glance: Pharmaceuticals companies Monday, 21 Jul 2014 | 11:37 AM ET

    Baxter International Inc. fell$. 37 or. 5 percent, to $76.15. Bristol-Myers Squibb Co. fell$. 28 or. 6 percent, to $48.84. Hospira fell$. 06 or. 1 percent, to $50.09.

  • Midday Glance: Medical Devices companies Friday, 18 Jul 2014 | 1:19 PM ET

    Allergan rose $1.25 or. 8 percent, to $167.07. Baxter International Inc. fell$. 25 or. 3 percent, to $76.00. Boston Scientific Corp. rose$. 18 or 1.4 percent, to $12.64.

  • July 18- Advertising company Interpublic Group of Cos Inc reported better-than-expected quarterly revenue, boosted by strong growth in the UK and higher ad spending in its core U.S. market. Interpublic's clients include General Motors, Unilever and Johnson& Johnson.

  • July 18- Advertising company Interpublic Group of Cos Inc reported better-than-expected quarterly revenue, boosted by a strengthening international market and higher ad spending in the United States. Interpublic's clients include General Motors, Unilever and Johnson& Johnson.

  • POWRANNA, Australia, July 18- Thousands of Black Angus bulls snort steam gently into the frigid early morning air at Tasmania's largest cattle feedlot as they jostle for space at a long grain trough.

  • ZURICH, July 16- Roche's experimental drug crenezumab failed to delay a decline in thinking and memory skills in people with Alzheimer's disease, a result likely to bolster a growing belief that drugs need to be given in earlier stages of the disease to show a benefit.

  • Roche Alzheimer's drug fails main goals in mid-stage study Wednesday, 16 Jul 2014 | 11:30 AM ET

    ZURICH, July 16- Roche said its experimental Alzheimer's drug failed to meet its main goals in a mid-stage study, a result likely to bolster the belief that drugs need to be given in earlier stages of the disease to slow patients' decline.

  • *JPMorgan, Goldman shares rally after earnings. NEW YORK, July 15- U.S. stocks pulled back on Tuesday after Federal Reserve Chair Janet Yellen and her fellow Fed policymakers raised concerns about "substantially stretched valuations" in some sectors. Facebook shares tumbled 1.1 percent to $67.17.

  • Stocks mixed, with Nasdaq hit by valuation worry Tuesday, 15 Jul 2014 | 4:46 PM ET
    Trader on the floor of the New York Stock Exchange.

    Stocks fell Tuesday after Federal Reserve Chair Janet Yellen said the central bank could hike rates sooner than expected.

  • *JPMorgan, Goldman rally after results, boosting Dow. *Germany's ZEW sentiment reading at lowest level since January 2013. JPMorgan Chase& Co and Goldman Sachs outperformed after reporting strong results.

  • Bonds flat on steady policy message from Yellen Tuesday, 15 Jul 2014 | 3:38 PM ET
    A trader signals an offer in a Treasury note options pit at the CME Group in Chicago.

    Treasurys whipsawed after congressional testimony from Fed Chair Janet Yellen indicated concern over 'substantially stretched' asset prices.